- Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Papillomavirus Research.
- Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993-2016. J Med Screen.
- Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol.
- Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs. J Am Soc Cytopathol.
- The projected timeframe until cervical cancer elimination in Australia. Lancet PH.
- Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: example from New Zealand. Vaccine.
- Should cervical cancer screening be performed before age 25? J Low Genit Tract Dis.
- The impact of ten years of HPV vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill.
- Australian Paediatric Surveillance Unit Annual Report, 2017. Commun Dis Intell Q Rep.
- Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia. Cancer Epidemiol.
- Human papillomavirus vaccination update: nonavalent vaccine and the two-dose schedule. Australian Journal of General Practice.
- Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study. Vaccine.
- Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention. JMIR Res Protoc.
- Cervical screening in HPV-vaccinated populations. Climacteric.
- IPVS Statement Moving towards Elimination of Cervical Cancer as a Public Health Problem. Papillomavirus Research.
- Spatial variation in cervical cancer screening participation & outcomes among Indigenous and non-Indigenous Australians in Queensland. Geographical Research.
- Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program. Vaccine.
- Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012). PLoS One.
- Safety of human papillomavirus vaccines: An updated review. Drug Saf.
- National Cervical Screening Programme Annual Report 2015. National Screening Unit: Wellington.
- Authors’ reply to “Comments on: Safety of Human Papillomavirus Vaccines: An Updated Review”. Drug Saf.
- Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination. Journal of Infectious Diseases.
- Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia. PLoS ONE.
- Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia. BMJ Open.
- A prospective study of the incidence of juvenile onset recurrent respiratory papillomatosis after implementation of a National HPV Vaccination Program. J Infect Dis.
- Australia on-track to be the first country to achieve cervical cancer elimination.
- Self-collection for under-screened women as part of the renewed National Cervical Screening Program: A Pilot Study. Current Oncology.
- Completing the cervical screening pathway: An Australian pilot of HPV self-collection for under-screened and never-screened women. Current Oncology.
Association between visual inspection of the cervix with acetic acid examination and high‐risk human papillomavirus infection, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in Papua New Guinea. The Australian and New Zealand Journal of Obstetrics and Gynaecology (ANZJOG).
- Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Commun Dis Intell.
- Innovative approaches to cervical cancer screening in low- and middle-income countries. Climacteric.
- Ambiguous bodies, uncertain diseases: knowledge of cervical cancer in Papua New Guinea. Ethn Health.
- “Lest we forget” as we move forward with cervical screening. Aust N Z J Obstet Gynaecol.